Risk factors for developing drug-related problems in patients with cardiovascular diseases attending Gondar University Hospital, Ethiopia

Background: Cardiovascular diseases (CVDs) are often accompanied with comoribidities and complications leading to taking multiple drugs and thus are more liable to be exposed to drug-related problems (DRPs). DRPs can occur at any stages of medication process from prescription to follow-up treatment....

Full description

Bibliographic Details
Main Authors: Ousman Abubeker Abdela, Akshaya Srikanth Bhagavathula, Henok Getachew, Yohannes Kelifa
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2016-01-01
Series:Journal of Pharmacy and Bioallied Sciences
Subjects:
Online Access:http://www.jpbsonline.org/article.asp?issn=0975-7406;year=2016;volume=8;issue=4;spage=289;epage=295;aulast=Abdela
_version_ 1818407176946843648
author Ousman Abubeker Abdela
Akshaya Srikanth Bhagavathula
Henok Getachew
Yohannes Kelifa
author_facet Ousman Abubeker Abdela
Akshaya Srikanth Bhagavathula
Henok Getachew
Yohannes Kelifa
author_sort Ousman Abubeker Abdela
collection DOAJ
description Background: Cardiovascular diseases (CVDs) are often accompanied with comoribidities and complications leading to taking multiple drugs and thus are more liable to be exposed to drug-related problems (DRPs). DRPs can occur at any stages of medication process from prescription to follow-up treatment. However, a few studies have assessed the specific risk factors for occurrence of at least one potential DRP per patient with CVDs in sub-Saharan African region. Aim: We aim to assess the risk factors for developing potential DRPs in patients with CVDs attending Gondar University Referral Hospital (GUH). Methodology: This was a cross-sectional study. A structured systematic data review was designed focusing on patients with CVDs (both out and inpatients) with age >18 years of both genders attending GUH from April to June 2015. All DRPs were assessed using drugs.com and Medscape. The causes of DRPs were classified using Pharmaceutical Care Network Europe version 6.2. Risk factors that could cause DRPs were assessed using binary logistic regression showing odds ratio with 95% confidential interval. Statistical significance was set at P< 0.05. Results: A total of 227 patients with CVDs were reviewed with a mean age of 52.0 ± 1.7 years. Majority were females (143, 63%), outpatients (133, 58.6%), and diagnosed with heart failure (71, 31.3%). Diuretics (199, 29.5%) were the most commonly prescribed drugs. A total of 265 DRPs were identified, 63.4% of patients have at least one DRP (1.17 ± 1.1). The most common DRPs were found to be an inappropriate selection of drug (36.1%) and dose (24.8%). The most identified risk factors causing DRPs were: Need of additional drug therapy and lack of therapeutic monitoring. Conclusion: The most identified risk factors for developing DRPs were the need of additional drug therapy and lack of therapeutic monitoring. There is a need for clinical pharmacist interventions to monitor and prevent the risk of developing DRPs and contribute to improve the clinical outcome in patients with CVDs.
first_indexed 2024-12-14T09:23:41Z
format Article
id doaj.art-fda2b307e5084a2fb1ce98dae3031a60
institution Directory Open Access Journal
issn 0975-7406
language English
last_indexed 2024-12-14T09:23:41Z
publishDate 2016-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Journal of Pharmacy and Bioallied Sciences
spelling doaj.art-fda2b307e5084a2fb1ce98dae3031a602022-12-21T23:08:14ZengWolters Kluwer Medknow PublicationsJournal of Pharmacy and Bioallied Sciences0975-74062016-01-018428929510.4103/0975-7406.199335Risk factors for developing drug-related problems in patients with cardiovascular diseases attending Gondar University Hospital, EthiopiaOusman Abubeker AbdelaAkshaya Srikanth BhagavathulaHenok GetachewYohannes KelifaBackground: Cardiovascular diseases (CVDs) are often accompanied with comoribidities and complications leading to taking multiple drugs and thus are more liable to be exposed to drug-related problems (DRPs). DRPs can occur at any stages of medication process from prescription to follow-up treatment. However, a few studies have assessed the specific risk factors for occurrence of at least one potential DRP per patient with CVDs in sub-Saharan African region. Aim: We aim to assess the risk factors for developing potential DRPs in patients with CVDs attending Gondar University Referral Hospital (GUH). Methodology: This was a cross-sectional study. A structured systematic data review was designed focusing on patients with CVDs (both out and inpatients) with age >18 years of both genders attending GUH from April to June 2015. All DRPs were assessed using drugs.com and Medscape. The causes of DRPs were classified using Pharmaceutical Care Network Europe version 6.2. Risk factors that could cause DRPs were assessed using binary logistic regression showing odds ratio with 95% confidential interval. Statistical significance was set at P< 0.05. Results: A total of 227 patients with CVDs were reviewed with a mean age of 52.0 ± 1.7 years. Majority were females (143, 63%), outpatients (133, 58.6%), and diagnosed with heart failure (71, 31.3%). Diuretics (199, 29.5%) were the most commonly prescribed drugs. A total of 265 DRPs were identified, 63.4% of patients have at least one DRP (1.17 ± 1.1). The most common DRPs were found to be an inappropriate selection of drug (36.1%) and dose (24.8%). The most identified risk factors causing DRPs were: Need of additional drug therapy and lack of therapeutic monitoring. Conclusion: The most identified risk factors for developing DRPs were the need of additional drug therapy and lack of therapeutic monitoring. There is a need for clinical pharmacist interventions to monitor and prevent the risk of developing DRPs and contribute to improve the clinical outcome in patients with CVDs.http://www.jpbsonline.org/article.asp?issn=0975-7406;year=2016;volume=8;issue=4;spage=289;epage=295;aulast=AbdelaCardiovascular diseasesclinical pharmacistdrug related problemsethiopiaPharmaceutical Care Network Europerisk factors
spellingShingle Ousman Abubeker Abdela
Akshaya Srikanth Bhagavathula
Henok Getachew
Yohannes Kelifa
Risk factors for developing drug-related problems in patients with cardiovascular diseases attending Gondar University Hospital, Ethiopia
Journal of Pharmacy and Bioallied Sciences
Cardiovascular diseases
clinical pharmacist
drug related problems
ethiopia
Pharmaceutical Care Network Europe
risk factors
title Risk factors for developing drug-related problems in patients with cardiovascular diseases attending Gondar University Hospital, Ethiopia
title_full Risk factors for developing drug-related problems in patients with cardiovascular diseases attending Gondar University Hospital, Ethiopia
title_fullStr Risk factors for developing drug-related problems in patients with cardiovascular diseases attending Gondar University Hospital, Ethiopia
title_full_unstemmed Risk factors for developing drug-related problems in patients with cardiovascular diseases attending Gondar University Hospital, Ethiopia
title_short Risk factors for developing drug-related problems in patients with cardiovascular diseases attending Gondar University Hospital, Ethiopia
title_sort risk factors for developing drug related problems in patients with cardiovascular diseases attending gondar university hospital ethiopia
topic Cardiovascular diseases
clinical pharmacist
drug related problems
ethiopia
Pharmaceutical Care Network Europe
risk factors
url http://www.jpbsonline.org/article.asp?issn=0975-7406;year=2016;volume=8;issue=4;spage=289;epage=295;aulast=Abdela
work_keys_str_mv AT ousmanabubekerabdela riskfactorsfordevelopingdrugrelatedproblemsinpatientswithcardiovasculardiseasesattendinggondaruniversityhospitalethiopia
AT akshayasrikanthbhagavathula riskfactorsfordevelopingdrugrelatedproblemsinpatientswithcardiovasculardiseasesattendinggondaruniversityhospitalethiopia
AT henokgetachew riskfactorsfordevelopingdrugrelatedproblemsinpatientswithcardiovasculardiseasesattendinggondaruniversityhospitalethiopia
AT yohanneskelifa riskfactorsfordevelopingdrugrelatedproblemsinpatientswithcardiovasculardiseasesattendinggondaruniversityhospitalethiopia